2 Mg Borviz Bortezomib Injection

This medication is an antineoplastic agent, prescribed for multiple myeloma and mantle cell lymphoma. It works by killing cancer cells. Bortezomib harms cancer cells causing their death. It comes as a solution for injection to be administered by a healthcare provider into the vein. Adult: IV- 1.3 mgm2 as bolus on days 1, 4, 8 and 11 of a 21-day cycle, followed by a 10-day rest period (days 12-21).